openPR Logo
Press release

Weitz & Luxenberg Wins $8 Million in Obstetrical Malpractice Case

11-14-2006 04:08 PM CET | Politics, Law & Society

Press release from: Weitz & Luxenberg

A leading medical malpractice and personal injury litigation law firm in America

A leading medical malpractice and personal injury litigation law firm in America

November 14, 2006, New York, NY—Medical errors account for nearly 100,000 deaths each year, estimates the Institute of Medicine, a Washington-based policy research organization. Many other patients live with debilitating conditions after falling victim to such negligence. Toward its ongoing dedication to hold doctors and other medical professionals accountable for the tragic injuries they inflict with substandard care, Weitz & Luxenberg, P.C., one of the leading medical malpractice and personal injury litigation law firms in America, is gratified by a recent obstetrical malpractice suit that yielded an $8 million settlement.

The case, filed in Kings County, New York, involved an infant who suffered brain damage at birth due to a traumatic and delayed delivery. The child now lives with an intractable seizure disorder—seizures that cannot be controlled with medication. The monetary award derived from this case will be used by his young parents to help mitigate the overwhelming cost of caring for him for the rest of his life.

Allan Zelikovic, who handled the case and is the head of the Medical Malpractice Unit at Weitz & Luxenberg said, “The care this young mother received would be considered appalling even if it had occurred in a Third-World country. As a result, this child, his parents, and his siblings will be responsible for his care for the rest of his life. The only consolation is that now they know they can afford to get him the best treatment.”

The hospital resident tasked with measuring the fetal heart rate encountered the baby’s face in the birth canal. This revealed that a caesarian section was indicated, as opposed to a vaginal birth. However, when she relayed this information to the attending physician, he summarily dismissed it, insisting upon delivering the baby “naturally.”

As a result, the baby suffered facial abrasions due to his facial skin being stretched excessively while being forced down the birth canal face-first. Upon his delivery, it also became obvious that his neurological status was compromised by both the blunt force trauma of the delivery and the deprivation of oxygen. Appallingly, all of this irreversible damage could have been prevented with entirely standard medical care.

Those who have been affected by medical malpractice may contact Weitz & Luxenberg by calling our Client Relations Department at 800-476-6070 or e-mailing clientrelations@weitzlux.com. Please also visit our website: www.weitzlux.com

David Kufeld
Weitz & Luxenberg
180 Maiden Lane
New York, NY
1-800-476-6070
clientrelations@weitzlux.com

About Weitz & Luxenberg: Weitz & Luxenberg, P.C., founded in 1986, is one of the leading plaintiffs, mass torts, product liability, and personal injury litigation law firms in America. A forerunner in the legal fight against environmental polluters, Weitz & Luxenberg has worked with clients harmed by MTBE, asbestos, chromium, fluoride, lead, PCE and other toxins. Weitz & Luxenberg represent over 50 water providers whose wells have been contaminated with MTBE and several communities around the country for the personal injuries and property damage they have suffered as a result of pollution. The firm has played leading roles in national and local litigations involving asbestos, DES, silicone breast implants, medical malpractice, and general negligence, among others. The firm has won numerous cases involving dangerous pharmaceuticals, including Vioxx, achieving a $13.5 million verdict against Merck & Co. (docket No. ATLL129605).

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Weitz & Luxenberg Wins $8 Million in Obstetrical Malpractice Case here

News-ID: 12796 • Views:

More Releases from Weitz & Luxenberg

Weitz & Luxenberg Cited for Top NYS 2014 Product Liability Cases by New York Law …
Weitz & Luxenberg, P.C. has been recognized by the New York Law Journal for winning the top three product liability verdicts in New York State in 2014. “The lawyers and law firms who are ranked in this special section represent the best of the best in 2014,” New York Law Journal associate publisher Farrell McManus wrote in the Journal’s “Top Verdicts New York 2014.” He continued, “Their zealous advocacy on
Mesothelioma Treatment Tomudex Receives International Support
Mesothelioma Treatment Tomudex Receives International Support
Mesothelioma treatment Tomudex, made by a global pharmaceutical company, is receiving approval from a panel of international experts. Tomudex falls in the group of anti-cancer drugs known as antineoplastics. It prevents cell growth. By doing so, it leads to the elimination of tumors. In a study examining people diagnosed with pleural mesothelioma, the use of Tomudex in conjunction with Platinol resulted in improved response rates of 23.6% as opposed to
New Mesothelioma Treatment Technique Developed
New Mesothelioma Treatment Technique Developed
Extrapleural pneumonectomy, a surgical procedure that removes mesothelioma cancer from the lining of the lung, has been reported to be an effective new mesothelioma treatment technique. The technique was developed by Dr. Sugarbaker, the co-leader of the Brigham Biomedical Research Institute's Cancer Research Center, Chief of the Institute's Division of Thoracic Surgery and a Professor of Oncologic Surgery at Harvard Medical School. The surgical technique was applied on a mesothelioma patient
Mesothelioma Cancer: Possible Treatment Option
Mesothelioma Cancer: Possible Treatment Option
An experiment carried out in Memorial Sloan-Kettering Cancer Center, Mount Sinai School of Medicine and the Medical University Vienna has tested the effectiveness of a genetically modified virus to treat mesothelioma in animals. The virus is known as Newcastle Disease Virus (NDV). Animals with mesothelioma administered with multiple doses of NDV responded better than those that received a single dose. The use of a genetically engineered virus to disrupt the function

All 5 Releases


More Releases for America

Waterproof Labels Market Outlook, Supportive Judgments | SATO America, LANGGUTH …
Report Ocean recently published a new report on the Global Waterproof Labels Market. The study has an in-depth analysis of the forecast period from 2021-2025. The report reveals a comprehensive picture of the Waterproof Labels Market situation, taking into consideration all major trends, market dynamics, and competitive factors. Additionally, the report contains key statistics concerning the Waterproof Labels Market situation of the leading key players, key market trends, and potential
Textiles Market Analysis Report, Regional Outlook - Europe, North America, South …
Adroit Market Research has announced the addition of the “Global Textiles Market Size Status and Forecast 2025”, The report classifies the global Textiles in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Textiles Speaker market, analyzes and researches the Textiles Speaker development status and forecast in Europe, North America, Central America, South America, Asia Pacific
Blow Molding Machinery Market Analysis Report, Regional Outlook - Europe, North …
Adroit Market Research has announced the addition of the “Global Blow Molding Machinery Market Size Status and Forecast 2025”, The report classifies the global Blow Molding Machinery in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Blow Molding Machinery Speaker market, analyzes and researches the Blow Molding Machinery Speaker development status and forecast in Europe,
Global Gaucher Disease Market 2018 Covering North America, South America, Europe
Gaucher Disease Market Summary The Global Gaucher Disease Market is defined by the presence of some of the leading competitors operating in the market, including the well-established players and new entrants, and the suppliers, vendors, and distributors. The key players are continuously focusing on expanding their geographic reach and broadening their customer base, in order to expand their product portfolio and come up with new advancements. Gaucher Disease market size to maintain the average annual growth
Epigenetics Market by End Users, and by Geography North America, Latin America, …
Increasing research to study the epigenetics of the genome (study called epigenomics) is expected to boost growth of the epigenetics market over the forecast period. Genome-wide epigenetic studies play an important role in the diagnostics of human diseases. Moreover, implementation of epigenetics for oncology research is estimated to propel the growth of epigenetics market. For instance, Constellation Pharmaceuticals, in April 2018, invested US$ 100 million for development of cancer epigenetics
Spas and Beauty Salons Market - South America, Central America and North America …
Consumers’ changing perception towards personal care coupled with continuous strive to improve general well-being are generating a positive impact on the spas and beauty salons industry. Growing consumer need to improve personal appearance and well-being has increased the demand for wellness solutions. Spa centers and beauty salons, in order to meet the increasing demand for unique spa and beauty services, are constantly striving to improve their services by focusing on